IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.
On-Demand Educational Webinars
Developing a clinically integrated supply chain can lead to organizational savings, a decrease in ordering of supplies outside of the supply chain,…
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…
On-Demand Educational Webinars
In many organizations, the relationship between supply chain and accounts payable is strained due to lack of clarity and ownership. This webinar…